About

Glass Current publishes Wide Anchor 33 to help San Francisco residents and their families make clearer, evidence-first decisions about complex treatment claims. Our mission is to distinguish investigational research from unregulated offerings, and to situate ibogaine alongside established care while being explicit about limits, uncertainty, and safety.

Our editorial approach

How we source information

We prioritize primary registries, peer-reviewed literature, and official guidance when framing claims about treatment safety and evidence. Our work is cross-checked against clinical registries and recognized databases where possible; for instance, systematic reviews and trial registries are used to confirm existence and design of trials rather than rely on promotional summaries. Where appropriate, we reference established repositories such as ClinicalTrials.gov to verify study registration and outcomes, rather than secondary reporting.

What we cover

Landscape photo accompanying a section describing the types of content Wide Anchor 33 covers, showing a clinical-like tabletop and notes
Photography supports editorial clarity and a calm presentation.

We publish explainers about evidence quality, summaries of regulatory and legal frameworks, and practical safety-focused considerations. Our pages are organized into clear topical sections — background on research methods, what claims are supported by evidence, and how to weigh risk — and we link between related pages so readers can move from overview to detail without losing context. For example, if you want to compare care options we provide navigational pages like a concise overview of services and their roles within the same site.

Editorial principles

  • Independence: We do not accept payments that influence coverage; our analyses are evidence-driven.
  • Transparency: We cite registries and primary literature where available and explain limitations plainly.
  • Safety-first: We foreground potential harms and practical safety concerns alongside any discussion of potential benefits.
  • Plain language: Technical material is translated so non-specialists can use it.
  • Humility about uncertainty: We mark where evidence is preliminary or inconclusive and avoid overstating results.

"Glass Current is an independent resource on ibogaine for San Francisco residents evaluating claims, legal realities, safety concerns, and treatment options." — mission statement

How information is vetted

Our editorial checks include cross-referencing trial registry entries, examining primary studies, and consulting authoritative public health resources when summarizing risk. When we state factual claims about treatment mechanisms or legal context we aim to cite reliable sources such as government health pages or established academic overviews; for example, official clinical trial registries (ClinicalTrials.gov) and peer-reviewed synthesis inform our summaries. We also draw on broad reference material — for methodology explanations, an accessible overview like the one on Evidence-based medicine on Wikipedia can help readers understand levels of evidence, while clinical trial registry practices are described at ClinicalTrials.gov.

Because our audience values local relevance, we link internally to related site pages from each article; for instance, when readers arrive at a topic page they can follow contextual cross-links back to our homepage via narrative phrases such as the site's overview of aims and scope, and to service-oriented guidance via prose anchors like our services overview that situates information within broader care options.

Independent by design

Wide Anchor 33 is published by Glass Current as an independent information resource. We are not a clinic, medical provider, or licensed treatment center; our content does not constitute medical or legal advice. Readers should consult licensed clinicians and official health agencies for clinical decisions. For completeness and to avoid misleading claims we occasionally link to specialized resources; for example, when discussing investigational therapies we may reference peer-reviewed literature summaries and authoritative pages such as the U.S. National Library of Medicine overviews (nlm.nih.gov) to contextualize research conventions.

Where specific services or experimental interventions are discussed on the site, we use inline links to primary project pages or trial registries to let readers see original descriptions; an example of cross-domain verification is an external clinical-oriented resource that documents investigations into ibogaine-related approaches at ibogaine treatment for Parkinson's overview.

Closing note

If you rely on our pages, treat them as a starting point for informed conversations with clinicians and local health services. We keep the site's structure intentionally simple so readers can move between topical summaries and deeper pages without losing the editorial frame; for example, readers exploring treatment-reality analysis can jump to /treatment-reality/ from within topical prose, and our plain-language service summaries link back into the site's explanatory pages.